| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Synthesis and characterization of novel 6-fluoro-4-piperidinyl-1,2-benzisoxazole amides and 6-fluoro-chroman-2-carboxamides: antimicrobial studies.
|
Bioorg Med Chem
|
2005
|
2.32
|
|
2
|
Microwave-assisted synthesis of N-alkylated benzotriazole derivatives: antimicrobial studies.
|
Bioorg Med Chem Lett
|
2005
|
1.37
|
|
3
|
Synthesis of pharmaceutically important condensed heterocyclic 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivatives as antimicrobials.
|
Eur J Med Chem
|
2006
|
1.22
|
|
4
|
Synthesis of novel isoxazolidine derivatives and studies for their antifungal properties.
|
Eur J Med Chem
|
2003
|
1.16
|
|
5
|
Synthesis of new bioactive venlafaxine analogs: novel thiazolidin-4-ones as antimicrobials.
|
Bioorg Med Chem
|
2005
|
1.15
|
|
6
|
2-(2-(2-Ethoxybenzoylamino)-4-chlorophenoxy)-N-(2-ethoxybenzoyl)benzamine inhibits EAT cell induced angiogenesis by down regulation of VEGF secretion.
|
Bioorg Med Chem Lett
|
2007
|
0.93
|
|
7
|
Chondroitinase-mediated degradation of rare 3-O-sulfated glucuronic acid in functional oversulfated chondroitin sulfate K and E.
|
J Biol Chem
|
2007
|
0.92
|
|
8
|
Conformational studies on five octasaccharides isolated from chondroitin sulfate using NMR spectroscopy and molecular modeling.
|
Biochemistry
|
2007
|
0.87
|
|
9
|
N-Substituted-2-butyl-5-chloro-3H-imidazole-4-carbaldehyde derivatives as anti-tumor agents against Ehrlich ascites tumor cells in vivo.
|
Med Chem
|
2007
|
0.86
|
|
10
|
Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells.
|
Invest New Drugs
|
2007
|
0.86
|
|
11
|
Neutralization of haemorrhagic activity of viper venoms by 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-5-carbonitrile.
|
Basic Clin Pharmacol Toxicol
|
2011
|
0.82
|
|
12
|
Determination of iduronic acid and glucuronic acid in sulfated chondroitin/dermatan hybrid chains by (1)H-nuclear magnetic resonance spectroscopy.
|
Glycoconj J
|
2008
|
0.81
|
|
13
|
Screening of quinoline, 1,3-benzoxazine, and 1,3-oxazine-based small molecules against isolated methionyl-tRNA synthetase and A549 and HCT116 cancer cells including an in silico binding mode analysis.
|
Org Biomol Chem
|
2015
|
0.80
|
|
14
|
Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of MMP-13 hemopexin domain.
|
PLoS One
|
2010
|
0.78
|
|
15
|
Synthesis, characterization, antimicrobial and single crystal X-ray crystallographic studies of some new sulfonyl, 4-chloro phenoxy benzene and dibenzoazepine substituted benzamides.
|
Eur J Med Chem
|
2006
|
0.78
|
|
16
|
Cobb syndrome.
|
J Assoc Physicians India
|
1996
|
0.78
|
|
17
|
N-[4-Cyano-3-(trifluoro-meth-yl)phen-yl]-2-eth-oxy-benzamide.
|
Acta Crystallogr Sect E Struct Rep Online
|
2010
|
0.75
|
|
18
|
Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.
|
PLoS One
|
2017
|
0.75
|
|
19
|
N-[4-Cyano-3-(trifluoro-meth-yl)phen-yl]-2-meth-oxy-benzamide.
|
Acta Crystallogr Sect E Struct Rep Online
|
2010
|
0.75
|
|
20
|
Synthesis, characterization and in vitro anti-tumor activities of novel 9-ethyl-9H-purine derivatives.
|
Invest New Drugs
|
2009
|
0.75
|